GuideAugust 10, 2026 · 1 min read

Anavar (Oxandrolone): The Mild-Profile Oral

Research compounds for laboratory use only · not medical advice

Oxandrolone's high anabolic-to-androgenic ratio, its ~9–12 hour half-life, and the 10 mg tablet math for research protocols.

Anavar is the tablet researchers reach for when the word “mild” matters. Not weak — mild in the sense of a deliberately tilted anabolic-to-androgenic ratio.

The molecule

Oxandrolone (C₁₉H₃₀O₃, ≈ 306 g/mol) is a 17α-alkylated oral androgen — the alkylation keeps it alive through first-pass metabolism, and the half-life lands around 9–12 hours. That’s the oral’s tradeoff: it works without injection, but daily or split dosing is required because it clears in hours.

The “mild” reputation

Anavar’s research references center on its high anabolic-to-androgenic ratio — more anabolic signal relative to androgenic side effects than most compounds in its class. That’s why it shows up in protocols that want protein-synthesis work without a strong androgenic footprint. The oral androgens comparison puts it next to Winstrol and Dianabol for a direct look.

Tablet math

Anavar ships as 10 mg precision-dosed tablets — no reconstitution, no syringe units. When a research method calls for molar concentrations, the molecular weight calculator does the conversion. Room temperature storage, ethanol/oil soluble.

See Anavar for CAS, purity and full specifications, and the ester master reference for where the orals sit in the kinetic table.

For laboratory research use only. Not medical advice.

Last updated September 9, 2026

FAQ

Frequently asked questions

What is oxandrolone?

Oxandrolone (Anavar) is a 17α-alkylated oral androgen with a high anabolic-to-androgenic ratio, supplied as 10 mg precision-dosed tablets.

How long is its half-life?

Around 9–12 hours — oral androgens clear in hours, not days, which is why protocols dose daily or split the tablet.

Why is it called 'mild'?

Its androgenic profile is low relative to its anabolic activity, which is why research references it when protocols want to minimize androgenic signal while maintaining protein-synthesis work.